TXA for GI Bleeds? The HALT-IT Trial

July 15, 2020 00:26:28
TXA for GI Bleeds?  The HALT-IT Trial
Critical Care Perspectives in Emergency Medicine
TXA for GI Bleeds? The HALT-IT Trial

Jul 15 2020 | 00:26:28

/

Show Notes

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. 

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

September 19, 2017 00:32:38
Episode Cover

ED Mechanical Ventilation Pearls

In this podcast we discuss the pearls and perils of ED mechanical ventilation.  What are the numbers you NEED to know! We also discuss...

Listen

Episode 0

May 15, 2019 00:29:21
Episode Cover

Refractory Vasodilatory Shock

Emergency medicine, critical care, and acute care providers evaluate, resuscitate, and manage patients with shock on a daily basis.  Despite initial efforts, a select...

Listen

Episode 0

March 25, 2017 00:17:05
Episode Cover

High Dose NTG in ACPE

ED Pharmacist extraordinaire Jill Logan joins CCPEM to discuss the use of high-dose nitroglycerin in patients with acute cardiogenic pulmonary edema.  Is it safe? ...

Listen